Equity (Tables)

12 Months Ended

Sep. 30, 2023

Equity [Abstract]

Schedule of Stock Options Activity

The following table summarizes stock option activity under the Equity Plans for the fiscal year ended September 30, 2023:

	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)	Aggregate Intrinsic Value (*) (in thousands)
Outstanding as of September 30, 2022	9,981	$	4.52
Granted	—	—
Exercised	—	—
Forfeited	—	—
Expired	976	3.84
Outstanding as of September 30, 2023	9,005	$	4.59	1.30	$	—
Exercisable as of September 30, 2023	9,005	$	4.59	1.30	$	—
Vested and expected to vest as of September 30, 2023	9,005	$	4.59	1.30	$	—

___________________________________________

(*)    Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option’s exercise price and the underlying stock price. For the fiscal year ended September 30, 2022, the intrinsic value of options exercised was $0.

Schedule of Restricted Stock Activity

The following table summarizes the activity related to RSUs subject to time-based vesting requirements for the fiscal year ended September 30, 2023:

	RSUs
	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2022	2,947,130	$	3.90
Granted	2,896,650	1.00
Vested	(1,314,313)	3.72
Forfeited	(499,391)	2.55
Non-vested as of September 30, 2023	4,030,076	$	2.04

Schedule of Performance Share Activity

The following table summarizes the activity related to PSUs for the fiscal year ended September 30, 2023:

	PSUs
	Number of Shares (at target)	Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2022	1,809,053	$	4.37
Granted	634,650	0.97
Vested	(291,285)	2.47
Forfeited	(448,000)	3.81
Non-vested as of September 30, 2023	1,704,418	$	3.57

Schedule of Stock-based Compensation Expense - By Award Type

The following table sets forth stock-based compensation expense by award type:

	Year Ended September 30,
(in thousands)	2023		2022
RSUs and RSAs	$	4,203	$	2,576
PSUs	2,306		2,314
Outside director equity awards and fees in common stock	378		484
Total stock-based compensation expense	$	6,888	$	5,374

Schedule of Stock-based Compensation Expense - By Expense Type

The following table sets forth stock-based compensation expense by expense type:

	Year Ended September 30,
(in thousands)	2023		2022
Cost of revenue	$	1,742	$	952
Selling, general, and administrative	1,324		3,591
Research and development	3,823		831
Total stock-based compensation expense	$	6,888	$	5,374

Schedule of (Loss) Income Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net loss per share:

	Year Ended September 30,
(in thousands, except per share data)	2023		2022
Numerator
Net loss from continuing operations	$	(49,413)	$	(40,761)
(Loss) income from discontinued operations including loss on disposal of $9.6 million, net of tax benefit of $0	$	(25,946)	$	16,428
Net loss	$	(75,359)	$	(24,333)
Denominator
Weighted average number of shares and preferred warrants outstanding - basic	51,510		37,269
Effect of dilutive securities
Stock options	—		—
PSUs, RSUs, and restricted stock	—		—
Weighted average number of shares and preferred warrants outstanding - diluted	51,510		37,269
Loss from continuing operations per share - basic and diluted	$	(0.96)	$	(1.09)
Loss from discontinued operations per share - basic and diluted	$	(0.50)	$	0.44
Net loss per share - basic and diluted	$	(1.46)	$	(0.65)
Weighted average antidilutive options, unvested RSUs and RSAs, unvested PSUs and ESPP shares excluded from the computation	3,305		858

Schedule of Common Stock Reserved for Future Issuances

Common stock reserved for future issuances as of September 30, 2023 was as follows:

	Amount
Exercise of outstanding stock options	9,005
Unvested RSUs	4,030,076
Unvested PSUs (at 100% maximum payout)	1,704,418
Issuance of stock-based awards under the Equity Plans	513,561
Purchases under the officer and director share purchase plan	88,741
Total reserved	6,345,801